The YBR284W Antibody is a specialized immunoglobulin designed to target the protein encoded by the YBR284W gene in Saccharomyces cerevisiae (strain S288c), commonly known as baker’s yeast. This antibody is widely used in molecular biology research to study protein localization, gene expression, and post-translational modifications in yeast models .
The YBR284W gene is part of the S. cerevisiae reference genome (strain S288c). While its exact biological function remains under investigation, it is annotated as a non-essential gene with potential roles in cellular processes such as chromatin organization or metabolic regulation. Key features include :
Protein Properties: Molecular weight and isoelectric point are derived from sequence analysis.
Expression: Detected under standard laboratory growth conditions.
Post-Translational Modifications: No confirmed modifications reported, though yeast histones (e.g., H3-K42 methylation) are studied in related contexts .
The antibody enables visualization of the YBR284W protein’s subcellular distribution, contributing to hypotheses about its role in yeast physiology .
Studies leveraging this antibody have explored genetic interactions with other yeast genes, particularly in screens for synthetic lethality or epistasis .
The polyclonal nature of the antibody allows detection of multiple epitopes on the target protein, enhancing sensitivity in assays like Western blotting .
Antibody Validation: Specificity confirmed via immunoblotting against yeast lysates, with no cross-reactivity observed in knockout strains .
Functional Insights: While YBR284W is not essential for viability, its deletion may affect growth under stress conditions, suggesting auxiliary roles in cellular adaptation .
KEGG: sce:YBR284W
STRING: 4932.YBR284W
YBR284W is a putative metallo-dependent hydrolase superfamily protein in Saccharomyces cerevisiae (baker's yeast). Although it shows structural similarity to AMP deaminases, it lacks key catalytic residues and does not rescue the purine nucleotide metabolic defect of the quadruple aah1 ade8 amd1 his1 mutant. The protein is of particular interest because the null mutant exhibits several distinctive phenotypes including longer telomeres, altered Ty mobility, and decreased resistance to rapamycin and wortmannin .
YBR284W is not an essential gene but is induced in response to hydrostatic pressure. It has a paralog, YJL070C, that arose from whole genome duplication, making it an interesting subject for studying gene duplication and functional divergence. Researchers investigate YBR284W to understand its contribution to chronological lifespan, stress responses, and potential alternative functions in nucleotide metabolism despite lacking canonical catalytic activity .
The gene has shown significant phenotypes in multiple screens, particularly in chronological lifespan assays where knockout strains show dramatic reductions (in the 0.01-0.06 percentile range), indicating its importance in cellular aging processes .
Antibodies against yeast proteins like YBR284W are typically generated using one of several established approaches. The most common method involves heterologous expression of the full-length protein or specific domains in E. coli, followed by chromatographic purification. For instance, as demonstrated with other yeast proteins like RFA, the purified recombinant protein (without affinity tags) is used to immunize rabbits to produce polyclonal antibodies .
For YBR284W specifically, researchers would likely clone the ORF into a bacterial expression vector, optimize expression conditions, purify the protein, and use it for immunization. Alternatively, synthetic peptides corresponding to unique regions of YBR284W can be conjugated to carrier proteins and used as immunogens, particularly if the full-length protein proves difficult to express or purify .
The resulting antisera are typically purified through affinity chromatography using the immobilized antigen. Quality control includes testing various dilutions (ranging from 1:5,000 to 1:20,000) to determine optimal specificity and sensitivity for different applications such as Western blotting, immunoprecipitation, and chromatin immunoprecipitation .
YBR284W antibodies serve multiple critical applications in yeast research, similar to other yeast protein antibodies like anti-RFA. Primary applications include:
Western blotting: For detecting and quantifying YBR284W protein expression levels in various experimental conditions. TCA-precipitated protein extracts are typically used, with antibody dilutions ranging from 1:5,000 to 1:20,000 depending on antibody quality and specificity .
Immunoprecipitation (IP): For isolating YBR284W and identifying its protein interaction partners. This technique is particularly valuable for understanding protein complex formation and regulatory mechanisms .
Chromatin Immunoprecipitation (ChIP): If YBR284W associates with DNA or chromatin-bound proteins, ChIP can be used to identify genomic binding sites. Based on experience with other yeast proteins, high dilutions (1:20,000) are often effective for reducing background in ChIP applications .
PCR-based assays: When combined with techniques like those used for detecting Ty3 integration events, antibodies can help investigate potential roles of YBR284W in processes like retrotransposition, particularly given its known effect on Ty mobility when deleted .
These applications help researchers investigate the protein's localization, expression patterns, interaction network, and functional role in various cellular processes.
Effective sample preparation is crucial for successful detection of YBR284W by Western blotting. Based on protocols used for similar yeast proteins, the following methods are recommended:
TCA precipitation method: As demonstrated in yeast protein studies, trichloroacetic acid (TCA) precipitation is particularly effective for extracting total yeast proteins while minimizing degradation. This approach involves harvesting cells, resuspending in TCA buffer, vortexing with glass beads, and precipitating proteins with cold TCA .
Denaturing extraction: For whole-cell extracts, a denaturing buffer containing 9M urea and 5mM EDTA can be used with glass bead disruption, as described for detection of other yeast proteins. This method is particularly useful for membrane-associated or insoluble proteins .
Rapid extraction method: For routine analysis, the Hoffman and Winston method can be adapted, where cells are suspended in extraction buffer (10mM Tris-HCl pH 8.0, 1mM EDTA, 100mM NaCl, 2% Triton X-100, 1% SDS) and vortexed with glass beads in the presence of phenol:chloroform .
For optimal results, samples should be freshly prepared and immediately loaded or stored at -80°C with protease inhibitors. SDS-PAGE separation typically requires 10% polyacrylamide gels, followed by transfer to PVDF membranes (like Immobilon-P) for immunoblotting .
Thorough validation of YBR284W antibody specificity is essential to avoid misleading results. The following comprehensive validation strategy is recommended:
Genetic validation: Test the antibody against wild-type yeast and YBR284W deletion strains. Complete absence of signal in the deletion strain confirms specificity. This approach has been successfully used for validating other yeast protein antibodies .
Molecular weight verification: Confirm that the antibody detects a protein of the expected molecular weight (as predicted from the YBR284W sequence) in Western blot analyses. Be aware that post-translational modifications may cause shifts in apparent molecular weight .
Paralog discrimination testing: Given that YBR284W has a paralog (YJL070C), test specificity against both proteins to ensure the antibody can discriminate between them. This may require expressing each protein separately or using strains with individual deletions .
Peptide competition assays: Pre-incubate the antibody with the immunizing antigen prior to application. Specific signals should be abolished or dramatically reduced in these competition experiments .
Cross-reactivity assessment: Test the antibody against a panel of unrelated yeast proteins to identify any non-specific binding, particularly noting that unspecific bands at approximately 150 kDa have been observed with some yeast antibodies .
This systematic approach to validation will ensure reliable and reproducible results in research applications.
Non-specific binding is a common challenge when working with yeast protein antibodies. Based on experiences with similar antibodies, the following troubleshooting approach is recommended:
Optimize antibody dilution: Test a range of dilutions (1:5,000 to 1:20,000) to identify the optimal concentration that maximizes specific signal while minimizing background. Experience with yeast antibodies shows that higher dilutions (1:20,000) often produce cleaner results while maintaining detection of the target protein .
Adjust blocking conditions: Test different blocking agents (5% non-fat dry milk, 3% BSA, or commercial blocking reagents) and extend blocking time to reduce non-specific binding. For yeast proteins, BSA sometimes provides superior results compared to milk-based blockers .
Modify washing protocols: Increase the number and duration of washes using PBS-T or TBS-T with varying concentrations of Tween-20 (0.05-0.1%). Adding low concentrations of SDS (0.01-0.05%) to wash buffers can help reduce stubborn background .
Test alternative extraction methods: Different protein extraction techniques can affect background. Compare TCA precipitation, urea-based extraction, and standard lysis buffers to determine which provides the cleanest results for YBR284W detection .
Use highly specific detection systems: Enhanced chemiluminescence systems like ECL Plus can improve signal-to-noise ratio. Consider secondary antibodies with minimal cross-reactivity to yeast proteins .
Address known non-specific bands: With some yeast antibodies, consistent non-specific bands (e.g., at ~150 kDa) have been observed. Document these to distinguish them from specific signals in your experiments .
This systematic approach should help resolve non-specific binding issues encountered with YBR284W antibodies.
Successful immunofluorescence detection of YBR284W in yeast cells requires careful optimization of fixation and permeabilization procedures to preserve antigenicity while enabling antibody access through the yeast cell wall. Based on protocols for similar yeast proteins, the following methods are recommended:
Formaldehyde fixation: Fix log-phase yeast cultures with 3.7-4% formaldehyde for 30-60 minutes at room temperature. This preserves cellular structures while maintaining protein antigenicity. The fixation time may need optimization specifically for YBR284W .
Cell wall digestion: Treat fixed cells with zymolyase (100T at 0.5-1 mg/ml) or lyticase in sorbitol buffer (1.2M sorbitol, 0.1M potassium phosphate pH 7.5) for 20-30 minutes at 30°C to create spheroplasts, allowing antibody penetration .
Permeabilization optimization: Test different permeabilization agents (0.1-0.5% Triton X-100, 0.1-0.5% NP-40, or methanol/acetone treatment) to determine which provides optimal antibody accessibility while preserving YBR284W epitopes .
Blocking step: Block non-specific binding sites with 1-3% BSA or 5-10% normal serum from the same species as the secondary antibody. PBS containing 0.1% BSA and 0.1% Tween-20 often works well for yeast immunofluorescence .
Antibody incubation: Use primary antibody at higher concentrations than for Western blotting (typically 1:100 to 1:1000), and incubate overnight at 4°C to maximize specific binding .
For mounting, antifade agents containing DAPI or other nuclear counterstains can help identify cellular compartments and provide context for YBR284W localization patterns.
Chromatin immunoprecipitation (ChIP) protocols for YBR284W require specific optimization to ensure efficient and specific precipitation of protein-DNA complexes. Based on ChIP methods used for other yeast proteins, the following optimizations are recommended:
Crosslinking optimization: Test different formaldehyde concentrations (0.5-1.5%) and incubation times (10-20 minutes) at room temperature to achieve optimal crosslinking without overfixation, which can mask epitopes. For proteins with weaker DNA interactions, consider using dual crosslinkers like formaldehyde followed by disuccinimidyl glutarate (DSG) .
Cell lysis and chromatin fragmentation: Optimize sonication conditions (amplitude, cycle number, duration) to generate chromatin fragments of 200-500 bp. For yeast cells, more vigorous sonication is typically required due to the cell wall. Monitor fragmentation by agarose gel electrophoresis .
Antibody dilution: Start with high dilutions (1:20,000) as recommended for other yeast protein antibodies in ChIP applications, then adjust based on results. Pre-clearing lysates with protein A/G beads can reduce background .
Washing stringency: Implement a stringent washing protocol with increasing salt concentrations (150mM to 500mM NaCl) to remove non-specific interactions while preserving specific YBR284W-DNA complexes .
Controls and normalization: Include input DNA controls, IgG negative controls, and positive controls targeting known chromatin-associated proteins like histones. For data analysis, normalize to input and negative controls to account for background binding .
Downstream analysis: Depending on research questions, analyze precipitated DNA by quantitative PCR for specific loci or next-generation sequencing for genome-wide binding patterns .
This optimized ChIP protocol should enable effective investigation of potential YBR284W interactions with chromatin, which may provide insight into its cellular functions.
Cross-reactivity between YBR284W and its paralog YJL070C presents a significant challenge for antibody specificity. This issue arises from their evolutionary relationship as paralogs resulting from whole genome duplication, leading to considerable sequence similarity . Research indicates several approaches to address this challenge:
Sequence homology assessment: Perform detailed sequence alignment between YBR284W and YJL070C to identify regions of high and low conservation. Low-conservation regions are optimal targets for generating paralog-specific antibodies .
Epitope mapping: If using existing antibodies, conduct epitope mapping to determine which protein regions are recognized. This can be accomplished through peptide arrays or fragmentation analysis to identify precisely where cross-reactivity might occur .
Validation in deletion strains: Test antibodies in single deletion strains (ΔybrW284W and ΔyjlC070C) as well as double deletion strains. This genetic approach is the most definitive way to assess specificity and cross-reactivity potential .
Peptide-directed antibodies: Consider generating antibodies against synthetic peptides corresponding to non-conserved regions unique to YBR284W. While such antibodies may have lower affinity than those raised against the full-length protein, they can offer superior specificity .
Immunodepletion strategy: For mixed samples potentially containing both paralogs, sequential immunoprecipitation with paralog-specific antibodies may help distinguish signals from each protein .
Understanding and addressing potential cross-reactivity is essential for accurate interpretation of experimental results, particularly in studies examining the distinct functions of these paralogous proteins.
Karyotype verification: Before conducting experiments with YBR284W knockout strains, verify their karyotype using techniques such as comparative genomic hybridization (CGH) or quantitative PCR targeting multiple loci on chromosome XI to confirm whether aneuploidy is present in your specific strain .
Create independent knockouts: Generate new YBR284W deletion strains using alternative methods like CRISPR-Cas9 rather than relying solely on strains from the Yeast Deletion Project. This can help determine which phenotypes are directly linked to YBR284W loss versus chromosomal abnormalities .
Complementation testing: Reintroduce the wild-type YBR284W gene on a plasmid to the knockout strain. Phenotypes directly caused by YBR284W deletion should be rescued, while those resulting from aneuploidy typically persist .
Include chromosome XI dosage controls: Create control strains with an extra copy of chromosome XI but with intact YBR284W to distinguish aneuploidy effects from gene deletion effects .
Comparative phenotypic analysis: Compare phenotypes of your YBR284W knockout with the published patterns for other mutants constructed by the same research group (Hoepfner et al., 2014). Similar phenotypic patterns may indicate aneuploidy contributions .
The comprehensive data in the table below shows the dramatic phenotypic effects of YBR284W deletion, with some potentially influenced by aneuploidy:
| Screen name | Normalized phenotypic value (NPV) | Percentile |
|---|---|---|
| hap a | chronological lifespan | time [9 d] | SC + 4(Trp, Leu, Ura, His) | -7.88 | 0.01% |
| hap a | growth (spot assay) | expression of alpha-synuclein | -7.29 | 0.02% |
| hap a | growth (colony size) | SGEPF E. purpurea extract [1.3 mg/mL] | -6.93 | 0.04% |
| hom | growth (pooled culture) | st027038 [51.00 uM] | -6.75 | 0.05% |
| hap a | chronological lifespan | time [11 d] | SC + 4(Trp, Leu, Ura, His) | -6.68 | 0.06% |
This careful control strategy will help distinguish genuine YBR284W functions from artifacts related to chromosomal abnormalities .